Literature DB >> 12561914

Value of estimating intraocular antibody production in diagnosis of typical and atypical lesions of ocular toxoplasmosis.

M Fawzy1, L A Mahmoud, A E El Gindy, M A Hegab, M A Bahgat.   

Abstract

Serum and aqueous humor (AH) samples were collected from 45 patients: 20 with typically active or reactivated retinal lesions of Toxoplasma (Group I), 16 with atypical lesions (Group II) and 9 with old quiescent scars (Group III). Also, serum and AH samples were collected from 10 patients with chronic toxoplasmosis without any ocular manifestation (Group IV). T. gondii specific IgG, IgA and IgM antibodies were measured by ELISA in AH and serum and the intraocular (local) antibody production was determined by calculating Goldman-Witmer coefficient (G.W.C.). IgG antibodies were the only class detected in all sera of patients with ocular and nonocular toxoplasmosis. An intraocular IgG antibody synthesis was confirmed in 95% and 37.5% of patients with typical (Group I) and atypical (Group II) posterior uveitis respectively and in none of either patients with quiescent scars (Group III) or the ophthalmologically free patients (Group IV). As regard the typical active lesions, the sensitivity of the IgG assay (95%) was higher than that of IgA (60%) and IgM (5%) assays. Beside the conclusion that AH analysis to detect local antibody production is more reliable than the estimating of serum antibodies for the diagnosis of ocular toxoplasmosis, the detection of AH specific antibodies in 6 atypical cases, who were treated successfully by antitoxoplasmic therapy, represent a help to increase the number of uveitis cases in which specific treatment can be established.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 12561914

Source DB:  PubMed          Journal:  J Egypt Soc Parasitol        ISSN: 1110-0583


  5 in total

1.  Aqueous humor and serum immunoblotting for immunoglobulin types G, A, M, and E in cases of human ocular toxoplasmosis.

Authors:  Justus G Garweg; Silvia-Daniela L Garweg; Franziska Flueckiger; Patrick Jacquier; Matthias Boehnke
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

2.  The antibody response in experimental ocular toxoplasmosis.

Authors:  Justus G Garweg; Matthias Boehnke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 3.117

3.  Diagnostic approach to ocular toxoplasmosis.

Authors:  Justus G Garweg; Jolanda D F de Groot-Mijnes; Jose G Montoya
Journal:  Ocul Immunol Inflamm       Date:  2011-08       Impact factor: 3.070

4.  Toxoplasma gondii bradyzoites and tachyzoites isolation from vitreous of atypical necrotizing retinitis.

Authors:  Ranju Kharel Sitaula; Sagun Narayan Joshi; Ranjit Sah; Sushila Khadka; Anadi Khatri Kc; Bharat Mani Pokharel
Journal:  J Ophthalmic Inflamm Infect       Date:  2018-06-15

Review 5.  Ocular toxoplasmosis: a review of the current diagnostic and therapeutic approaches.

Authors:  Dimitrios Kalogeropoulos; Hercules Sakkas; Bashar Mohammed; Georgios Vartholomatos; Konstantinos Malamos; Sreekanth Sreekantam; Panagiotis Kanavaros; Chris Kalogeropoulos
Journal:  Int Ophthalmol       Date:  2021-08-09       Impact factor: 2.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.